HopeStage
Back to all studies
CompletedNCT00616889

Quetiapine use and sleep in bipolar depression

About this title

Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder

Read the official source — NCT00616889
Observational studyAges 18–65Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
KingstonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2006
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
Queen's University
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00616889
Official title
Show the full official title

Effects of Seroquel on Sleep Architecture in Patients With Bipolar Depression or Major Depressive Disorder - An Open Label Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Kingston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Queen's University, a university.

Did this study involve medication?

Yes. The study involved medication, including Seroquel.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies